reference/16598360

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16598360

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article
endingPage	22
issn	1078-0432
issueIdentifier	4
pageRange	1313-22
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1313
bibliographicCitation	Plummer R, Rees C, Hughes A, Beale P, Highley M, Trigo J, Gokul S, Judson I, Calvert H, Jackman A, Mitchell F, Smith R, Douglass E. A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor. Clin Cancer Res. 2003 Apr;9(4):1313–22. PMID: 12684399.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52a71683120658342bf8c5c73de9ee6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a98a20b1ff60a1ef7d8baea263b7560 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d9baac1fd9a74ec24715f51bf95b794 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_683b093a74b30ee8c87f7328cba5bf61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_214539c117f937a64cc0537ee9ab6cf0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2a6fcf6510ccd2381450cf1f8edae13 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dbd8a2631dc21bd7815e715155ad5f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f59edb2cb163dd9421e309667e30de6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3497b2504a9cb8aced29b9a82df0fd84 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcc86fefc3b6e9e615cbb7347f4c0794 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_615218ad15ccf5cb9be4921e3ba0d6bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8c892dd32e281830b54c04e2275775e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdb1c480a02471719a2ac6913a14ad4d
date	200304
identifier	https://pubmed.ncbi.nlm.nih.gov/12684399
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	A phase I trial of ZD9331, a water-soluble, nonpolyglutamatable, thymidylate synthase inhibitor
discusses	http://id.nlm.nih.gov/mesh/M0021454 http://id.nlm.nih.gov/mesh/M0022883 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0248470
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D013940Q000037 http://id.nlm.nih.gov/mesh/D011799Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014867Q000737 http://id.nlm.nih.gov/mesh/D000970Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011799Q000493 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008956
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f23da35a23be1387249189adc219228a http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9002f7b62e7223e85a4962c6cd6d9c18 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135430970 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13712 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.45

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128661307

Total number of triples: 66.